A major supplier to the NHS is at risk of becoming involved in American executions, after Alabama altered its lethal injection ‘cocktail’ to include a drug for which they are the only US supplier yet to put in place sufficient distribution controls.
Mylan pharmaceuticals, which describes itself as a “leading developer and supplier of generic medicines [to] wholesalers and throughout the National Health Service,” is a US Government-approved manufacturer of rocuronium bromide, a paralysing agent which Alabama now plans to use as the second part of a three-stage lethal injection process.
The paralysing agent is a particularly concerning element of the process, as it leaves the prisoner unable to speak or move, and therefore can mask the effects of a botched execution, in which the anaesthetic has failed.
Mylan is the only US-approved maker of the drug which has not responded to calls from stakeholders to put in place distribution controls to prevent its use in executions, making it the easiest source from which Alabama will be able to obtain it. As a result, legal charity Reprieve has warned Mylan that it may only be a matter of time before the state obtains their product, and uses it to kill. The state’s attorney general’s office is already seeking to set execution dates for nine people, in the wake of the adoption of Alabama’s new lethal injection ‘protocol.’
Despite being notified of the issue in October of last year, Mylan has failed to establish controls which would ensure that their products can still reach legitimate, medical users, but not executioners – a model which has been successfully established by many other major pharmaceutical companies.
In a letter sent to Mylan on September 30th, Maya Foa, Director of Reprieve’s Death Penalty team warns the company that it is “is the only FDA-approved manufacturer of rocuronium bromide which has no controls in place to prevent it being sold and used in executions in the USA,” and explains that there is therefore “a very real risk that Mylan may soon become the go-to provider of execution drugs for States across the country.”
However, she also explains that “there are simple and effective controls that a company like Mylan can put in place to ensure its medicines are sold for legitimate medical purposes, and not sold to prisons for use in lethal injection executions,” adding that “Over a dozen manufacturers have put such controls in place.”
Commenting, Maya Foa said: “Mylan is the only company we have worked with which has so far failed to take any concrete steps to prevent its medicines from being used to end the lives of prisoners in the USA. The NHS should think carefully about supporting a company which is apparently happy to see its medicines used in brutal executions.”
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.